ArticleOncology and therapy2016

Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple Myeloma.

Rachid C Baz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.